Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.90
  • 52 Week Low: 7.40
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 972,957
  • Market Cap: £38.00m
  • Beta: 0.80

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
57.93% below the market average57.93% below the market average57.93% below the market average57.93% below the market average57.93% below the market average
20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
37.2% below the market average37.2% below the market average37.2% below the market average37.2% below the market average37.2% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Price Chg 3m
88.64% below the market average88.64% below the market average88.64% below the market average88.64% below the market average88.64% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
7.79% above the market average7.79% above the market average7.79% above the market average7.79% above the market average7.79% above the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Momentum 20
5.84% below the market average5.84% below the market average5.84% below the market average5.84% below the market average5.84% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
73.3% below the market average73.3% below the market average73.3% below the market average73.3% below the market average73.3% below the market average
26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
22.64% below the market average22.64% below the market average22.64% below the market average22.64% below the market average22.64% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Cash
14.79% above the market average14.79% above the market average14.79% above the market average14.79% above the market average14.79% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
16.20% above the market average16.20% above the market average16.20% above the market average16.20% above the market average16.20% above the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 7.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.90
52 Week Low 7.40
Volume 972,957
Shares Issued 500.00m
Market Cap £38.00m
Beta 0.80

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Price Trend
59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average
18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:37 30,000 @ 7.60p
16:03 30,000 @ 7.60p
16:03 30,000 @ 7.60p
15:59 6,443 @ 7.76p
15:59 300 @ 7.75p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page